A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease

NCT01504295 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Alcoholism,
Alcoholic Liver Disease

Interventions

DRUG: Metadoxine

Sponsor

Brown University

Collaborators

[object Object]